Alnylam Pharmaceuticals | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 4.09B 483M 2025-08
Agios Pharmaceuticals USD 2B 66M 2025-08
Alnylam Pharmaceuticals USD 53.03B 10.5B 2025-08
Amgen USD 154.93B 4.8B 2025-08
Arrowhead Research USD 2B 182M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Incyte USD 17.01B 3.83B 2025-08
Ionis Pharmaceuticals USD 6.2B 94M 2025-08
Moderna USD 10.57B 101M 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Novartis USD 240.64B 6.39B 2025-08
PTC Therapeutics USD 3.48B 394M 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sanofi USD 121.02B 3.42B 2025-08
Sarepta Therapeutics USD 1.71B 30M 2025-08
Takeda JPY 6.72T 323.6B 2025-08
Tectonic Therapeutic USD 681M 234M 2024-12
Ultragenyx Pharmaceutical USD 2.27B 1.17B 2025-08
Vertex Pharmaceuticals USD 97.9B 16.43B 2025-08
Xencor USD 442M 117M 2025-08


Alnylam Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.